Can Theranos Raise New Capital?

A college dropout started a medical testing company 13 years ago. The company raised at least $750 million at a $9 billion valuation but its technology fell far short of the founder’s bold promises.

from Forbes – Tech http://ift.tt/1T9O6OS
via IFTTT